Skip to main content

Hyperhidrosis Treatment with Botulinum Toxin

  • Chapter
  • First Online:
Book cover Botulinum Toxin for Asians
  • 1212 Accesses

Abstract

Sweating, an essential physiological phenomenon for thermoregulatory control, is regulated by a control center in the preoptic area and anterior hypothalamus via a signal by the sympathetic nervous system which is stimulated when body core temperature is increased by the weather outside or physical activity [1]. While sweating generally occurs at the whole body in case with thermoregulatory control, however, sweating may occur focally in the palms, soles, and the axillae stimulated by stress, excitement, and pain regardless of body temperature. Hyperhidrosis can be defined as sweating that affects their daily lives without a discernible cause in excess of the normal physiological needs of the body [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sato K, Kang WH, Saga K, Sato KT. Biology of sweat glands and their disorders. II. Disorders of sweat gland function. J Am Acad Dermatol. 1989;20(5 Pt 1):713–26.

    Article  CAS  PubMed  Google Scholar 

  2. Atkins JL, Butler PE. Hyperhidrosis: a review of current management. Plast Reconstr Surg. 2002;110:222–8.

    Article  PubMed  Google Scholar 

  3. Altman RS, Schwartz RA. Emotionally induced hyperhidrosis. Cutis. 2002;69:336–8.

    PubMed  Google Scholar 

  4. Stolman LP. Treatment of hyperhidrosis. Dermatol Clin. 1998;16:863–9.

    Article  CAS  PubMed  Google Scholar 

  5. Ro KM, Cantor RM, Lange KL, Ahn SS. Palmar hyperhidrosis: evidence of genetic transmission. J Vasc Surg. 2002;35:382–6.

    Article  PubMed  Google Scholar 

  6. Strutton DR, Kowalski JW, Glaser DA, Stang PE. Poster presented at: American Academy of Dermatology 61st Annual Meeting; March 21-26, 2003; San Francisco. Abstract P362.

    Google Scholar 

  7. Herbst F, Plas EG, Függer R, Fritsch A. Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limbs. A critical analysis and long-term results of 480 operations. Ann Surg. 1994;220:86–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Drott C, Göthberg G, Claes G. Endoscopic transthoracic sympathectomy: an efficient and safe method for the treatment of hyperhidrosis. J Am Acad Dermatol. 1995;33:78–81.

    Article  CAS  PubMed  Google Scholar 

  9. Amir M, Arish A, Weinstein Y, Pfeffer M, Levy Y. Impairment in quality of life among patients seeking surgery for hyperhidrosis (excessive sweating): preliminary results. Isr J Psychiatry Relat Sci. 2000;37(1):25–31.

    CAS  PubMed  Google Scholar 

  10. Naumann MK, Hamm H, Lowe NJ, BOTOX Hyperhidrosis Clinical Study Group. Effect of Botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial. Br J Dermatol. 2002;147(6):1218–26.

    Article  CAS  PubMed  Google Scholar 

  11. Hölzle E, Braun-Falco O. Structural changes in axillary eccrine glands following long-term treatment with aluminium chloride hexahydrate solution. Br J Dermatol. 1984;110(4):399–403.

    Article  PubMed  Google Scholar 

  12. Togel B, Greve B, Raulin C. Current therapeutic strategies for hyperhidrosis: a review. Eur J Dermatol. 2002;12(3):219–23.

    PubMed  Google Scholar 

  13. Shrivastava SN, Singh G. Tap water iontophoresis in palmo-plantar hyperhidrosis. Br J Dermatol. 1977;96:189–95.

    Article  CAS  PubMed  Google Scholar 

  14. Sokolov VE, Shabadash SA, Zelikina TI. Innervation of eccrine sweat glands. Biol Bull Acad Sci USSR. 1980;7:331–46.

    CAS  PubMed  Google Scholar 

  15. Bushara KO, Park DM. Botulinum toxin and sweating. J Neurol Neurosurg Psychiatry. 1994;57:1437–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Schnider P, Moraru E, Kittler H, Binder M, Kranz G, Voller B, Auff E. Treatment of focal hyperhidrosis with Botulinum toxin type A: long-term follow-up in 61 patients. Br J Dermatol. 2001;145:289–93.

    Article  CAS  PubMed  Google Scholar 

  17. Heckmann M, Plewig G, Hyperhidrosis Study Group. Low-dose efficacy of Botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study. Arch Dermatol. 2005;141:1255–9.

    Article  CAS  PubMed  Google Scholar 

  18. de Bree R, Duyndam JE, Kuik DJ, Leemans CR. Repeated Botulinum toxin type A injections to treat patients with Frey syndrome. Arch Otolaryngol Head Neck Surg. 2009;135:287–90.

    Article  PubMed  Google Scholar 

  19. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. Br Med J. 2001;323:596–9.

    Article  CAS  Google Scholar 

  20. Lowe NJ, Glaser DA, Eadie N, Daggett S, Kowalski JW, Lai PY, North American Botox in Primary Axillary Hyperhidrosis Clinical Study Group. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol. 2007;56:604–11.

    Article  PubMed  Google Scholar 

  21. Cinà CS, Clase CM. The Illness Intrusiveness Rating Scale: a measure of severity in individuals with hyperhidrosis. Qual Life Res. 1999;8(8):693–8.

    Article  PubMed  Google Scholar 

  22. Devins GM, Edworthy SM, Seland TP, Klein GM, Paul LC, Mandin H. Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease and multiple sclerosis. J Nerv Ment Dis. 1993;181(6):377–81.

    Article  CAS  PubMed  Google Scholar 

  23. Bosdotter Enroth S, Rystedt A, Covaciu L, Hymnelius K, Rystedt E, Nyberg R, Naver H, Swartling C. Bilateral forearm intravenous regional anesthesia with prilocaine for Botulinum toxin treatment of palmar hyperhidrosis. J Am Acad Dermatol. 2010;63(3):466–74.

    Article  CAS  PubMed  Google Scholar 

  24. Simonetta Moreau M, Cauhepe C, Magues JP, Senard JM. A double-blind, randomized, comparative study of Dysport vs. BOTOX in primary palmar hyperhidrosis. Br J Dermatol. 2003;149(5):1041–5.

    Article  CAS  PubMed  Google Scholar 

  25. Osborn I. ‘Scalp Block’ during craniotomy: a classic technique revisited. J Neurosurg Anesthesiol. 2010;22:187–94.

    Article  PubMed  Google Scholar 

  26. Lindsay SL, Holmes S, Corbett AD, Harker M, Bovell DL. Innervation and receptor profiles of the human apocrine (epitrichial) sweat gland: routes for intervention in bromhidrosis. Br J Dermatol. 2008;159(3):653–60.

    Article  CAS  PubMed  Google Scholar 

  27. Heckmann M, Teichmann B, Pause BM, Plewig G. Amelioration of body odor after intracutaneous axillary injection of Botulinum toxin A. Arch Dermatol. 2003;139:57–9.

    Article  CAS  PubMed  Google Scholar 

  28. Heckmann M, Kütt S, Dittmar S, Hamm H. Making scents: improvement of olfactory profile after botulinum toxin-A treatment in healthy individuals. Dermatol Surg. 2007;33:S81–7.

    Article  CAS  PubMed  Google Scholar 

  29. He J, Wang T, Dong J. A close positive correlation between malodor and sweating as a marker for the treatment of axillary bromhidrosis with Botulinum toxin A. J Dermatolog Treat. 2012;23:461–4.

    Article  CAS  PubMed  Google Scholar 

  30. Lee JB, Kim BS, Kim MB, Oh CK, Jang HS, Kwon KS. A case of foul genital odor treated with Botulinum toxin A. Dermatol Surg. 2004;30:1233–5.

    PubMed  Google Scholar 

  31. Pérez Tato B, Zamora Martínez E, Sánchez Albisua B, Pérez González YC, Polimón Olabarrieta I, Marinero Escobedo S, Fernández LP. Facial and axillary apocrine chromhidrosis. Dermatol Online J. 2012;18:13.

    PubMed  Google Scholar 

  32. Wu JM, Mamelak AJ, Nussbaum R, Mc Elgunn PS. Botulinum toxin a in the treatment of chromhidrosis. Dermatol Surg. 2005;31:963–5.

    Article  CAS  PubMed  Google Scholar 

  33. Beer K, Oakley H. Axillary chromhidrosis: report of a case, review of the literature and treatment considerations. J Cosmet Dermatol. 2010;9:318–20.

    Article  PubMed  Google Scholar 

  34. Correia O, Duarte AF, Barros AM, Rocha N. Multiple eccrine hidrocystomas--from diagnosis to treatment: the role of dermatoscopy and botulinum toxin. Dermatology. 2009;219(1):77–9.

    Article  PubMed  Google Scholar 

  35. Lee YS, Choi JH, Aim HS, Chin HW, Lee SK. Multiple eccrine hidrocystomas treated with botulinum toxin type-A. Korean J Dermatol. 2011;49:283–6.

    CAS  Google Scholar 

  36. Blitzer A. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia. Otolaryngol Head Neck Surg. 2005;133:836-8; Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Moore D. Botulinum toxin types A and B for brow furrows: preliminary experiences with type B Botulinum toxin dosing. J Cosmet Laser Ther. 2002;4:15-8.

    Google Scholar 

  37. Glogau RG. Review of the use of Botulinum toxin for hyperhidrosis and cosmetic purpose. Clin J Pain. 2002;18(6 Suppl):S191–7.

    Article  PubMed  Google Scholar 

  38. Dressler D, Adib Saberi F, Benecke R. Botulinum toxin type B for treatment of axillary hyperhidrosis. J Neurol. 2002;249:1729–32.

    Article  CAS  PubMed  Google Scholar 

  39. Dressler D, Benecke B. Autonomic side effects of Botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol. 2003;49:34–8.

    Article  CAS  PubMed  Google Scholar 

  40. An JS, Hyun Won C, Si Han J, Park HS, Seo KK. Comparison of onabotulinumtoxinA and rimabotulinumtoxinB for the treatment of axillary hyperhidrosis. Dermatol Surg. 2015;41(8):960–7.

    Article  CAS  PubMed  Google Scholar 

  41. Comella CL, Jankovic J, Shannon KM, Tsui J, Swenson M, Leurgans S, Fan W, Dystonia Study Group. Comparison of Botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology. 2005;65:1423–9.

    Article  CAS  PubMed  Google Scholar 

  42. Baumann L, Slezinger A, Halem M, Vujevich J, Mallin K, Charles C, Martin LK, Black L, Bryde J. Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (Botulinum toxin type B) for the treatment of palmar hyperhidrosis. Dermatol Surg. 2005;31(3):263–70.

    Article  CAS  PubMed  Google Scholar 

  43. Baumann L, Slezinger A, Halem M, Vujevich J, Martin LK, Black L, Bryde J. Pilot study of the safety and efficacy of Myobloc (Botulinum toxin type B) for treatment of axillary hyperhidrosis. Int J Dermatol. 2005;44(5):418–24.

    Article  CAS  PubMed  Google Scholar 

  44. Dave SJ. Pilocarpine for the treatment of refractory dry mouth (xerostomia) associated with Botulinum toxin type B. Am J Phys Med Rehabil. 2008;87(8):684–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media Singapore

About this chapter

Cite this chapter

Seo, K.K. (2017). Hyperhidrosis Treatment with Botulinum Toxin. In: Botulinum Toxin for Asians. Springer, Singapore. https://doi.org/10.1007/978-981-10-0204-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-0204-5_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-0202-1

  • Online ISBN: 978-981-10-0204-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics